SciBase Successfully Registers Rights Issue and Share Conversion in Landmark Decision #Sweden #Stockholm #Nevisense #SciBase #BTA

SciBase Adjusts TO 2 Warrants Following Latest Rights Issue Announcement #Sweden #Stockholm #SciBase #Capital_Raise #TO_2_Warrants

SciBase Announces Share Issuance for Guarantee Compensation with Bergs Securities #Sweden #Stockholm #SciBase #Rights_Issue #Bergs_Securities

SciBase Successfully Completes Rights Issue with Strong Investor Support and $57.5 Million Raised #Sweden #Stockholm #Nevisense #SciBase #Bergs_Securities

SciBase Secures Financial Backing for Ongoing Rights Issue Amid Future Investments #Sweden #Stockholm #SciBase #Rights_Issue #Bergs_Securities

SciBase Secures Financial Backing Through Guarantee Commitment for Rights Issue #Sweden #Stockholm #SciBase #Rights_Issue #Bergs_Securities

SciBase Updates Trading Dates for Subscription Rights and Paid Shares on Nasdaq #Sweden #NASDAQ #Stockholm #SciBase #Rights_Issue

SciBase Issues New Information Document for Share Rights Issue, Aims for SEK 58 Million #Sweden #Stockholm #Nevisense #SciBase #Rights_Issue

SciBase Strengthens Partnership with Castle Biosciences Through New Order and Clinical Studies #Sweden #Stockholm #SciBase #Castle_Biosciences #Nevisense_Go

SciBase Strengthens Collaboration with Castle Biosciences Through Additional Order #Sweden #Stockholm #Nevisense #SciBase #Castle_Biosciences

SciBase Strengthens Partnership with Castle Biosciences Through New Order #Sweden #Stockholm #SciBase #Castle_Biosciences #Nevisense_Go

SciBase Moves to Strengthen Position with SEK 58 Million Rights Issue Strategy #Sweden #Stockholm #Nevisense #SciBase #Bergs_Securities